Develops veterinary diagnostic and pharmaceutical products for companion animals.
Zomedica Corp. is a pioneering veterinary health company dedicated to addressing the unique challenges faced by clinical veterinarians through the development of advanced products for companion animals. At the core of its mission is the TRUFORMA platform, a revolutionary point-of-care diagnostic tool designed to detect various disease states in dogs and cats swiftly. In addition to diagnostic innovations, Zomedica Corp. offers PulseVet, a cutting-edge therapy system that effectively treats musculoskeletal issues such as broken bones, tendonitis, and torn ligaments in both horses and small animals.
The company actively collaborates with industry leaders like Celsee, Inc., focusing on the development and commercialization of liquid biopsy assays. These assays and related consumables are pivotal in detecting cancer early in companion animals, enhancing diagnostic capabilities and treatment outcomes. Further expanding its technological footprint, Zomedica Corp. partners with Seraph Biosciences, Inc. to introduce a novel pathogen detection system that promises to set new standards in veterinary diagnostics.
Founded in 2015 and headquartered in Ann Arbor, Michigan, Zomedica Corp. has evolved significantly since its inception as Zomedica Pharmaceuticals Corp., rebranding in October 2020 to reflect its broader commitment to advancing veterinary care. With a forward-thinking approach and a strong emphasis on innovation, Zomedica Corp. continues to push boundaries in veterinary medicine, aiming to improve the health and well-being of companion animals globally.